Intercellular signals provided by growth and neurotrophic factors play a critical role during neurogenesis and as part of cellular repopulation strategies directed toward reconstruction of complex CNS circuitry. Local signals influence the differentiation of transplanted and endogenous neurons and neural precursors, but the cellular sources and control over expression of these molecules remain unclear. We have previously examined microenvironmental control in neocortex over neuron and neural precursor migration and differentiation following transplantation, using an approach of targeted apoptotic neuronal degeneration to specific neuronal populations in vivo. Prior results suggested the hypothesis that upregulated or reexpressed developmental signal molecules, produced by degenerating pyramidal neurons and/or by neighboring neurons or nonneuronal cells, may be responsible for observed events of directed migration, differentiation, and connectivity by transplanted immature neurons and precursors. To directly investigate this hypothesis, we analyzed the gene expression of candidate and control neurotrophins, growth factors, and receptors within regions of targeted neuronal cell death, first by quantitative Northern blot analysis and then by in situ hybridization combined with immunocytochemical analysis. The genes for BDNF, NT-4/5, trkB receptors, and to a lesser extent NT-3 were upregulated specifically within the regions of neocortex undergoing targeted neuronal degeneration and specifically during the period of ongoing pyramidal neuron apoptosis. Upregulation occurred during the same 3-week period as the previously investigated cellular events of directed migration, differentiation, and integration. No upregulation was seen in panels of control neurotrophins, growth factors, and receptors that are not as developmentally regulated in cortex or that are thought to have primary actions in other CNS regions. In situ hybridization and immunocytochemistry revealed that BDNF mRNA expression was upregulated specifically by local interneurons adjacent to degenerating pyramidal neurons. These findings suggest specific effects of targeted apoptosis on neurotrophin and other gene expression via mechanisms, including intercellular signaling between degenerating pyramidal neurons and surrounding interneurons. Further understanding of these and other controls over neocortical projection neuron differentiation may provide insight regarding normal neocortical development, intercellular signaling induced by apoptosis, and toward reconstruction and cellular repopulation of complex neocortical and other CNS circuitry. 1998 Academic Press
INTRODUCTION
Intercellular signaling plays a critical role during initial central nervous system (CNS) development and as part of cellular repopulation strategies, including those aimed at the reconstruction of complex neocortical and other CNS circuitry (8, 26, 36, 50, 58, 61, 63, 84, 85, 87) . The effectiveness of functional circuit reconstruction may depend critically on whether newly incorporated cells can undergo developmentally appropriate migration, differentiation, integration, and connectivity (16, 25, 30, 31, 39, 46, 47, 73, 70) . Local microenvironmental controls influence the differentiation of transplanted neurons, transplanted neural precursors, and recently identified endogenous precursors (6, 12, 60, 62, 72, 74) . However, the cellular sources and control over expression of locally produced signaling molecules remain unclear. Elucidation of such mechanisms, and approaches toward their further manipulation for control of neuronal differentiation and connectivity, will be useful in efforts toward specific and functional reconstruction of complex neocortical and other CNS circuitry.
We have examined local microenvironmental control over neuronal and neural precursor migration, differentiation, integration, and connectivity following transplantation using an approach of targeted apoptotic neuronal degeneration to specific neuronal populations in vivo. Neuronal degeneration of the population of lamina II/III neocortical pyramidal neurons with callosal projections in developing or adult cortex, e.g., is initiated by photoactivation of a retrogradely targeted chromophore, using very deeply penetrating longwavelength light. This results in highly specific neuronal cell death via apoptosis that occurs in the targeted population of neurons over the following 2-3 weeks (43, 44, 67, 68) . This relatively synchronous initiation of apoptosis mimics developmental programmed cell death, and our prior experiments suggested that these events induce signals activated during normal development and organizational refinement in the nervous system. Intermixed neurons of other types, glia, nonneural cells, and vasculature remain intact, allowing neighboring cell populations to alter cellular and molecular signaling in response to and in compensation for this perturbation of the neuronal environment and circuitry.
Previous studies using this experimental system have shown that immature neurons and neural precursors transplanted into regions of targeted pyramidal neuron degeneration undergo directed neuronal specification, long-distance migration, specific pyramidal neuron differentiation, afferent synaptic integration, and specific long-distance connectivity including projections to the correct contralateral hemisphere targets (27, 41, 67, 71) . These events of directed differentiation occur from 3 days to 3-4 weeks following initiation of cell death, coincident with the period of ongoing targeted pyramidal neuron apoptosis. These events do not occur in intact cortex or in a variety of control conditions, including excitotoxic neuronal loss; with distant transplants; or if transplantation is delayed beyond this 3-to 4-week time period. Taken together, these prior results suggested the hypothesis that upregulated or reexpressed developmental signal molecules, produced by the degenerating pyramidal neurons and/or by neighboring neurons or nonneuronal cells, may be responsible for the observed events of directed migration, differentiation, and connectivity.
To directly investigate this hypothesis, we analyzed the gene expression of candidate and control neurotrophins, growth factors, and receptors within regions of targeted neuronal cell death. These candidate and control molecules can be divided into three groups: (1) neurotrophins and receptors known to be developmentally regulated during initial corticogenesis, including BDNF, NT-4/5, and NT-3, and the neurotrophin receptors trkB and trkC; (2) neurotrophins and receptors that are not as developmentally regulated in cortex, but are present in adult cortex, including NGF and its cognate receptor trkA; and (3) growth factors that are thought to have primary action in other regions within the CNS, including bFGF, ciliary neurotrophic factor (CNTF), and leukemia inhibitory factor (LIF) (16, 20, 22, 23, 33, 42, 48, 49, 52, 78) . The second and third groups were analyzed as controls for specificity and to further test the hypothesis that developmentally relevant molecules were responsible for the observed events. We first examined gene expression by quantitative Northern blot analysis. After finding specific temporally and spatially defined reexpression of genes for the developmental candidate group, we investigated the cellular source of BDNF and trkB upregulation by in situ hybridization combined with immunocytochemical analysis using cell-type-specific markers. A preliminary report of some of this material has has been presented (81) .
MATERIALS AND METHODS

Animals
A total of 136 C57B1/6J mice from our institutional colony were used for these experiments: 108 for Northern blot analysis (96 experimentals and 12 controls); 16 for in situ hybridization (10 experimentals and 6 controls); 9 for dual in situ hybridization and immunocytochemistry (6 experimentals and 3 controls); and 3 controls to morphologically characterize pyramidal neurons and interneurons by immunocytochemistry.
Targeting of Callosal Projection Neurons
Retrograde targeting of contralateral callosal projection neurons was performed as previously described ( Fig. 1) (27, 43, 67, 69) . Briefly, postnatal day 0 (P0) pups were deeply anesthetized and the skull was exposed by a dorsal midline incision. A series of 9 to 12 microinjections of latex nanospheres conjugated with chlorin e 6 was placed unilaterally at equally spaced intervals across the length and width of the motor cortex, which successfully labeled callosal neurons in layer II/III and V of the contralateral hemisphere. The overlying skin was sutured closed following injections, and pups were returned to the litter for maternal care. Injections with the retrograde label Fluorogold were performed in a similar manner into adult mice (27) to identify callosal projection neurons in selected controls.
Photolytic Induction of Apoptotic Cell Death
At 4 weeks of age, the mice were deeply anesthetized with Avertin, skin overlying the cortex was incised and bilaterally reflected, and the area contralateral to the injection site was exposed by craniotomy. A continuouswave, long wavelength (674 nm) laser with custom optics (Candela Lasers, MA) was used to illuminate a 3-mm cortical target area resulting in slow, progressive, apoptotic degeneration of neurons labeled with chlorin e 6 ( Fig. 1) (43, 44) . Three dimensional cytoarchitecture of the cortex was maintained unperturbed, leaving other neurons, nonneural cell types, and vasculature completely intact.
RNA Isolation
At various times (1 h, 1, 3, 6, 8, 10, 14, 21 days) following photoactivation and initiation of progressive neuronal degeneration, microdissected tissue samples were collected from the targeted neocortical regions; from control regions both immediately adjacent to and distant from the site of neuronal degeneration in experimental mice; and from homologous cortex of age-matched control mice (Fig. 1) . Tissue sections of approximately 5 ϫ 5 ϫ 1.2 mm, spanning the thickness of cortex, were collected. All sections were rapidly frozen at Ϫ80°C for RNA preparation.
Total cellular RNA was extracted from frozen tissue by a standard RNAzolB/chloroform procedure (Biotecx protocol, Houston, TX). Tissue was homogenized in RNAzolB (100 mg/ml RNAzolB), and chloroform (1:10 v/v) was added to the sample solution, followed by thorough mixing. The sample was incubated on ice for 5 min and centrifuged at 14,000 rpm for 15 min at 4°C. The aqueous phase was then transferred to new tubes and mixed with isopropanol (1:1). RNA was pelleted after incubation for 15 min at 4°C and a further centrifugation as above. The RNA pellet was washed in FIG. 1. Schematic representation of sequential experimental steps in preparation and isolation of neocortical tissue samples from adult mice for analysis of candidate and control gene expression by quantitative Northern blot and in situ hybridization. Nanospheres carrying the photoactive chromophore chlorin e 6 were injected unilaterally into motor cortex of postnatal day 0 (P0) mice. Four weeks later (P28) the contralateral cortex was transdurally exposed to deeply penetrating near-infrared 674 nm light via beam-controlling optics that limit penetration depth, initiating progressive, apoptotic degeneration of targeted pyramidal neurons within lamina II/III. Experimental neocortical tissue samples (X) for quantitative Northern blot analysis were isolated by microdissection from 1 h to 21 days following initiation of targeted cell death. Control neocortical tissue samples from regions adjacent to and distant from the site of neuronal degeneration in experimental brains, and from intact, age-matched controls, were also isolated. Frozen coronal sections for in situ hybridization were prepared from day 3 or day 6 experimentals (both experimental and control regions) and from intact control mice. 75% cold ethanol (4:5), air dried, and resuspended in sterile milliQ H 2 O. RNA concentrations were determined by spectrophotometric analysis (DU-62 spectrophotometer) at 260/280 nm.
Northern Blot Analysis
A 30-µg aliquot of total RNA was denatured, electrophoresed through a 1.2% formaldehyde agarose gel, and transferred to a nylon filter (Biotrane, OH) in 20ϫ SSC (60, 61) . Filters were baked at 80°C for 2 h and prehybridized in Denhardt's solution (0.02% each of Ficoll, bovine albumin, and polyvinyl purrolidone 360, 0.75% NaCl, 5 mM EDTA (pH 8.0), 20 mg/ml glycine, 0.5% sodium dodecyl sulfate, 0.25 mg/ml sonicated salmon sperm DNA, and 50% (v/v) formamide). cDNA probes for hybridization (NGF (7) (70) , human, nucleotides 16-2532, EcoRI sites, pcDNA3 vector) were labeled by random priming (Boehringer Mannheim, Inc., Indianapolis, IN) to a specific activity of 10 8 -10 9 cpm/mg DNA. Hybridization was performed overnight at 45°C using 1-3 ϫ 10 6 cpm/ml 32 P-labeled cDNA/filter. The blots were washed, air dried, and exposed to DuPont Reflection film (NEN Research Products) at Ϫ80°C in the presence of intensifying screens (79, 80) .
When probing for specific growth factor, neurotrophin, and trk receptor mRNAs was complete, the filters were stripped and rehybridized to 32 P-␤-actin cDNA as a control to ensure equal loading of RNA on the gel and appropriate RNA transfer. Autoradiograms of each blot were analyzed by three independent and two blinded observers by densitometry using a Microtek 600ZS ScanMaker. Results were calculated as units of signal intensity above background levels. Levels of induction of specific messages were derived from the relative optical density value obtained after normalizing to the amount of ␤-actin RNA.
All plasmids were generous gifts from Dr. Andrew Welcher (Amgen, Inc., CA) and were grown and purified using a Maxi-prep kit (Promega; Madison, WI).
In Situ Hybridization
Brain tissue was isolated 3 or 6 days following initiation of targeted degeneration, frozen at Ϫ80°C, and sectioned at 15 µm on a cryostat (Jung Frigocut 2800E). BDNF and full-length trkB mRNA expression in coronal sections of cortex from mice with targeted neuronal degeneration was compared to mRNA expression in intact cortices of age-matched control mice and distant control cortical sections taken from the experimental mice (Fig. 1) . Tissue sections were mounted on glass slides (superfrost, Fischer Scientific) and stored at Ϫ80°C. Hybridization with both oligonucleotide probes and riboprobes, and exposure to photoemulsion, were performed as described elsewhere (3, 5, 54, 57, 63, 64) . Following hybridization, sections were counterstained with cresyl violet or reacted for immunocytochemical analysis. Positive hybridization was determined under bright field and Nomarski differential interference contrast (DIC) optics both quantitatively as described below and qualitatively, by comparison with background levels defined by using control sense probes on experimental sections, antisense probes on control sections, and 100-fold excess of cold oligo probes on sections.
Oligonucleotide probes for BDNF and catalytic trkB (53) (provided by Dr. Andrew Welcher; Amgen Inc., CA) were resuspended in H 2 O to a final concentration of 10 pm/µl, and were 3Ј end-labeled with terminal deoxynucleotidyl transferase (TDT kit, Gibco-BRL, Life Technologies; Grand Island, NY) according to standard procedures. An 80-ng oligonucleotide aliquot (40 ng/µl) was mixed with 5 ml 5ϫ TDT buffer, 12 µl 35 S-a-dATP (100 µCi) and 25 units TDT, and the final volume adjusted to 24 µl with H 2 O. The mixture was incubated at 37°C for 1 h.
Nensorb columns were washed sequentially with 3 ml methanol and 3 ml 0.1 M Tris-Cl (pH 8.0), then rinsed with 0.5 ml 0.1 M Tris-Cl (pH 8.0). Probes were eluted with 0.5 ml 20% ethanol, and the first 0.4-ml fractions were collected from the columns. A 2-µl sample from the collection solution was passed through a scintillation counter, and 10 5 -cpm probe was used for each experimental slide. Slides were fixed in 4% paraformaldehyde, dehydrated, and then prehybridized in 2ϫ SSC and 1ϫ Denhardt's solution for 1 h at 42°C. Hybridization was performed at 42°C for at least 16 h with 50% formamide, 4ϫ SSC (1ϫ SSC ϭ 150 mM sodium chloride, 15 mM sodium citrate, 200 mM NaH2PO4 (pH 8.0), 10% dextran sulfate, 1ϫ Denhardt's, 250 µg/ml yeast total RNA, and 1% sarcosyl). Following hybridization, slides were washed with 1ϫ SSC at 55°C (4 times for 15 min each) and once at room temperature for 1 h (54, 57, 64) . Controls included sections hybridized with a 100-fold excess of nonradioactive probe, radioactive control sense probes on experimental sections, and radioactive antisense probes on control sections.
Antisense and control sense 35 S-labeled BDNF cRNAs were transcribed from Bluescript plasmid containing a 1.1-kb rat BDNF insert (same as that used for Northern blot analysis) (3, 63) . Hybridization was performed at 50°C for at least 16 h with 50% formamide, 300 mM NaCl, 20 mM Tris-Cl (pH 7.4), 5 mM EDTA, 10 mM NaH2PO4 (pH 8.0), 10% dextran sulfate, 1ϫ Denhardt's, 500 µg/µl yeast total RNA, and 10 mM dithiothreitol (DTT). The slides were then washed as above. Controls included sections hybridized with radioactive control sense probes on experimental sections and radioactive antisense probes on control sections.
Quantitative Analysis of in Situ Hybridization
Following BDNF in situ hybridization, the average number of silver grains/cell was quantified using bright field illumination, high numerical aperature optics with shallow depth of field to isolate background cresyl violet counterstaining, and camera lucida documentation (Zeiss). A manual determination of the number of silver grains overlying each cell was performed and compared with the average background labeling for the same area and in control sections (using control sense probes on experimental sections, antisense probes on control sections, and 100-fold excess of cold oligo probes on sections). Background labeling was independently established for each section using a video-based image analysis system (Image Pro Plus) combined with manual counting over defined 10 4 -µm 2 areas. A cell was considered to be labeled when its silver grain density was twice that of the background level. Labeled cells were documented by camera lucida drawings. Labeled cells in intact cortices of control mice contained an average of 6.1 Ϯ 0.3 grains/cell, whereas labeled cells in mice with cortex undergoing neuronal degeneration contained an average of 21 Ϯ 0.95 grains/cell.
Immunocytochemistry
Immunocytochemical staining for the neuron-specific marker NeuN (56), GABA (Incstar), GFAP (Boehringer), and MBP (Boehringer) was performed on mounted vibratome or cryosections of brains fixed in 4% paraformaldehyde. Double labeling for both BDNF mRNA by in situ hybridization and cell type-specific markers by immunocytochemistry was performed in selected cases, following hybridization, but before emulsion application. Briefly, sections were postfixed, serially rinsed in PBS, incubated in block solution (10% goat serum in PBS), and placed in primary antibodies (1:100 dilution from Neu-N stock; 1:500 dilution from GABA stock; 1:4 dilution from GFAP stock; 1:500 dilution from MBP stock) for 2-12 h at 4°C. The tissue sections were then washed in PBS and incubated in secondary immunofluorescent antibody CY3 (1:1000 dilution from stock, Molecular Probes) or TRITC (1:500 dilution, Sigma). Histologic examination was performed using an epifluorescence microscope with high numerical aperture optics (Zeiss) or by laser confocal microscopy for dual retrograde and GABA labeling.
RESULTS
We first examined by quantitative Northern blot analysis the temporal course and regulation of gene expression for the three panels of candidate and control neurotrophins, growth factors, and receptors. This analysis covered the 3-week period following initiation of apoptotic pyramidal projection neuron degeneration.
Induction of trkB Receptor mRNA in Regions of Targeted Apoptotic Neuronal Degeneration
Coincident with the onset of the major wave of pyramidal neuron death approximately 1 to 3 days following photoactivation of the chlorin e 6 chromophore conjugated to latex nanospheres, there was a dramatic upregulation of the 4.8-kb transcript for the catalytic, full-length trkB receptor (Fig. 2) . The time course of this trkB response showed an earlier induction when compared with the upregulation of its primary ligands, BDNF and NT-4/5, described below. Maximal expression of trkB message, approximately threefold higher than controls, occurred 3 to 6 days after initiation of degeneration, and progressively returned to baseline over the following 11 days.
Induction of BDNF, NT-4/5, and NT-3 mRNA in Regions of Targeted Apoptotic Neuronal Degeneration
Northern blot analysis revealed even higher levels of increased expression of the developmentally regulated neurotrophins BDNF and NT-4/5, and to a lesser extent NT-3, over a timecourse that was somewhat more protracted and delayed in onset than that of trkB. Significant BDNF mRNA upregulation began by 3 days after initiation of apoptotic neuronal degeneration and peaked at days 6 to 8 (Fig. 3) . Maximal induction was approximately fivefold higher than control levels. Due to dilution effects stemming from overdissection of a larger 5 ϫ 5 ϫ 1.2-mm region of full thickness cortex to include the smaller 3-mm-diameter region of lamina II/III undergoing targeted neuronal death, combined with the in situ hybridization results below, we estimate that this actually represents approximately 50-to 60-fold induction of BDNF within the experimental region of lamina II/III (see Discussion). Significant increase of NT-4/5 mRNA also occurred by 3 days after initiation of apoptotic neuronal degeneration and peaked at day 8 (Fig. 4) . Maximal induction was approximately 3.5-fold higher than control levels, and levels returned to baseline between 14 and 21 days after initiation of neuronal degeneration. Upregulation of NT-3 mRNA was less dramatic (Fig. 5) . Induction was detected at day 3, reached a maximum of approximately 1.5-fold induction at day 8, and declined progressively over the next 1 to 2 weeks (data not shown).
These neurotrophin upregulations were maintained for 2 to 3 weeks following initiation of degeneration, exactly coinciding with the time period during which progressive apoptotic neuronal death was occurring and during which the cellular events of directed migration, differentiation, and integration occur by transplanted immature neurons and precursors.
Control expression levels were quite invariable in all of the groups, both between control regions tested and over the time course of analysis. The values for intact control, distant control, and adjacent control regions varied within groups and between groups for individual molecules by only 3 to 17%, typically less than 5-10%, throughout the period of analysis, with a maximal difference of 17% found between intact controls and distant controls for BDNF 10 days after initiation of degeneration. For example, BDNF controls varied by 3.8% between intact controls in different experiments at day 0-1; 4.1% between intact, adjacent, and distant controls at day 0-1; nonsignificant induction of only 1 Ϯ 0.043 (mean Ϯ SD) fold between intact controls over the timecourse of the experiment; and maximal, nonsignificant induction of 1 Ϯ 0.17-fold between adjacent and distant intact control regions at day 10. Controls over the period of analysis varied above and below the initial time value, without any systematic pattern of increase or decrease.
These alterations in gene expression were quite specific, spatially distinct, and temporally unique for individual upregulated molecules. There was no detectable mRNA upregulation for the developmental panel candidate trkC in regions undergoing neuronal cell death, despite a slight increase in expression of its primary ligand, NT-3 (Fig. 5) . There was no upregulation of the two control panels of growth factors and receptors that were analyzed both as controls for specificity and to further test the hypothesis that molecules relevant to initial corticogenesis underlie previously observed effects on immature neurons and neural precursors transplanted into regions of neocortex undergoing targeted neuronal apoptosis (Fig. 5) . Neither NGF nor trkA, its high affinity binding receptor, showed mRNA induction. Expression of mRNA for NGF, bFGF, CNTF, and LIF was not significantly altered above baseline levels.
Taken together, these results show that the genes for BDNF, NT-4/5, catalytic trkB receptors, and to a lesser extent NT-3 are upregulated specifically within the regions of neocortical lamina II/III undergoing targeted neuronal degeneration, and specifically during the period of ongoing pyramidal neuron apoptosis. Increased expression of these neurotrophins and the trkB receptor occurs during the same 3-week period as the previously investigated cellular events of directed migration, differentiation, and integration. 
Localization of Increased BDNF mRNA Expression to Interneurons within Regions of Targeted Apoptotic Neuronal Degeneration
After finding specific reexpression of genes for the developmental candidate group, we first investigated the cellular localization of BDNF and full-length trkB upregulation by in situ hybridization combined with Nissl staining, Nomarski DIC morphologic analysis, and double immunocytochemical labeling with the neuron-specific marker NeuN and the glial cell-typespecific markers GFAP and MBP. Characterization was limited to BDNF and the tyrosine kinase domaincontaining trkB mRNA, a ligand-receptor pair whose upregulation of both was quite significant following initiation of neuronal degeneration. The neurotrophin and receptor were both examined 3 and 6 days following initiation of neuronal degeneration, which were the times of maximal expression by Northern blot analysis. We found that BDNF mRNA expression is dramatically upregulated specifically in local GABAergic interneurons immediately adjacent to degenerating pyramidal neurons, uniquely within the regions of ongoing degeneration; BDNF expression is not increased in the degenerating pyramidal neurons themselves, nor in local astrocytes or oligodendroglia.
There was a 3-to 4-fold increase in the number of BDNF-labeled cells specifically within the superficial lamina II/III of neocortex undergoing targeted neuronal cell death, compared to intact cortices of agematched control mice and distant control cortical sections taken from the experimental mice (Fig. 6 ). The number of silver grains per cell was also significantly increased 3-to 4-fold in the experimental group, indicating elevated BDNF transcription. BDNF mRNA labeled cells in intact cortices of control mice contained an average of 6.1 Ϯ 0.3 grains/cell, whereas labeled cells in mice with cortex undergoing neuronal degeneration contained an average of 21 Ϯ 0.95 grains/cell. Together, these data revealed both a large increase in the number of cells with significant BDNF expression and a substantial increase in the absolute level of BDNF expression by these cells.
Initial morphologic analysis by cresyl violet and Nomarski DIC appearance, 10-15 µm diameter size, and cellular location immediately surrounding visibly degenerating pyramidal neurons suggested that the source of increased BDNF expression was local interneurons (Fig. 7A) . Labeling for full-length trkB mRNA revealed a less specific pattern of expression in multiple cell types, including the degenerating pyramidal neurons (data not shown). Representative samples were double labeled with NeuN, GFAP, or MBP to more definitively determine the BDNF-expressing cell phenotype as neuronal, astroglial, or oligodendroglial, respectively. Expression of BDNF was localized to small, ovoid, presumptive interneurons stained with NeuN and adjacent to the larger, dying pyramidal neurons (Fig. 7B-7D ). There was no staining for either GFAP or MBP on BDNF-expressing cells (data not shown). The identity of these presumptive interneurons was further examined through GABA immunocytochemistry and by analysis of retrograde FluoroGold transport from the contralateral hemisphere and thalamus, which would identify them as projection neurons rather than interneurons if present. These small, ovoid neurons are positive for the inhibitory neurotransmitter GABA, lack distant contralateral or thalamic projections, and surround FluoroGold-labeled pyramidal callosal projection neurons (Fig. 7E) , identifying them as interneurons.
DISCUSSION
Reconstruction of complex neocortical and other CNS neuronal circuitry via transplantation of immature neurons or precursors, or via manipulation of endogenous precursors, will require the combination of appropriate donor cells and a host environment that is both permissive and instructive for proper cellular migration, differentiation, and integration. We have investigated in vivo expression of a subset of candidate and control neurotrophins, growth factors, and neurotrophin receptors to directly test the hypothesis that the specific reexpression of developmental signaling molecules is at least partially responsible for the directed migration, differentiation, and integration of immature neurons and neural precursors transplanted within regions of mature neocortex undergoing targeted apoptotic degeneration of pyramidal projection neurons.
The results show that the genes for BDNF, NT-4/5, trkB receptors, and to a lesser extent NT-3 are upregulated specifically within the regions of neocortical lamina II/III undergoing targeted neuronal degeneration and specifically during the period of ongoing pyramidal neuron apoptosis. Increased expression of these neurotrophins and the trkB receptor occurs during the same 3-week period as the previously investigated cellular events of directed migration, differentiation, and integration. Cellular level investigation by combined in situ hybridization and immunocytochemistry revealed that BDNF mRNA expression is dramatically upregulated specifically in local interneurons immediately adjacent to degenerating pyramidal neurons, uniquely within the regions of ongoing degeneration; BDNF expression is not increased in the pyramidal neurons themselves, nor in local glia. These findings suggest specific effects of targeted apoptosis on neurotrophin and other gene expression via mechanisms including intercellular signaling between degenerating pyramidal neurons and surrounding interneurons.
Neurotrophins and other growth factors regulate neuronal differentiation and development of the mature neocortex (38) . Cortical precursors proliferate in the presence of bFGF (77, 78) and undergo increased early neuronal differentiation when exposed to PDGF in vitro (83) . NT-3 promotes differentiation of immature neurons and precursors into mature neurons (22) .
BDNF and NT-4/5 are thought to be important for later maturation and maintenance of cortical neurons (23, 75, 86) . Along with their receptor tyrosine kinase trkB, they are developmentally regulated during migration and differentiation of developing neocortical neurons (22, 23, 33) . High levels of expression of both BDNF and NT-3 are found in embryonic cortex, and their corresponding receptors trkB and trkC are found in the ventricular zone (1, 34, 42) . BDNF, NT-3, and NT-4/5 contribute to the complex control of migration, neurite extension, and segregation of axonal and dendritic arborization (4, 40, 41, 66) .
The present studies demonstrate by quantitative Northern blot analysis, in situ hybridization, and immunocytochemistry a similar temporally and spatially restricted upregulation of these neurotrophins within regions lamina II/III of mature mammalian cortex undergoing targeted, apoptotic neuronal degeneration. Ongoing death of pyramidal neurons with callosal projections initially induced elevated expression of full-length, catalytic trkB receptor mRNA that was observed within cells, including the degenerating neurons themselves. This was followed by a striking increase in transcription of the neurotrophins BDNF, NT-4/5, and to a lesser extent, NT-3. These alterations in gene expression were much later events, much more long-lasting, and much more specific than the typical nearly immediate increases in expression of many genes seen following less specific, necrotic, nervous system injury (excitotoxic injury, e.g.), which occur during the first 24 to 48 h. BDNF reexpression was further investigated and found to be upregulated specifically by GABAergic interneurons immediately adjacent to the degenerating pyramidal neurons. Upregulation was very specific both spatially and temporally, and no change was observed in two panels of control factors including NGF, bFGF, CNTF, and LIF, and the receptors, trkA and trk C.
Altered gene expression of BDNF, NT-4/5, NT-3, and trkB extended over the same 3-week period during which directed migration, differentiation, and integration have been observed by immature neurons and neural precursors transplanted into or adjacent to such regions of targeted pyramidal neuron degeneration (27, 43, 67) . The most pronounced upregulation was seen with the neurotrophin BDNF, whose signal peaked 6 to 8 days after induction of neuronal degeneration and gradually declined over a 2-week course thereafter. In these prior studies, transplanted neurons and precursors migrated to and underwent specific pyramidal neuron differentiation within regions of neocortical lamina II/III undergoing neuronal degeneration, suggesting extremely localized signaling mechanisms. As embryonic cortical neurons have been shown to respond to neurotrophins in vitro, and as the increased gene expression seen in the current experiments is limited to the regions of cortical projection neuron degeneration, the current results suggest that the altered expression of these neurotrophins, and likely a larger set of other factors not yet identified, could partially underlie the specific migration and differentiation of transplanted cells.
Technical reasons lead us to believe that the observed increases in gene expression are conservative estimates, and that the actual increases may be much higher than the 5-fold induction of BDNF mRNA, 3.5-fold induction of NT-4/5 mRNA, and 3-fold induction of full-length trkB mRNA detected by Northern blot analysis. Targeted neuronal degeneration was limited to callosal projection neurons within an approximately 3-mm diameter region of lamina II/III that is 350-400 µm deep (approximately 2.5 mm 3 ). However, samples dissected for mRNA quantitation were 5 ϫ 5 mm at the surface and spanned the approximately 1.2 mm depth of cortex including laminae I through VI (approximately 30 mm 3 ). Therefore, the actual experimental region comprised approximately one-twelfth of the sample, and we speculate that the increase in neurotrophin transcription may be underestimated by approximately 10-to 12-fold at the tissue level and much more at the cellular level. Taking into account this dilution factor, the upregulation of BDNF mRNA in regions of pyramidal neuron apoptosis may be more likely a 50-to 60-fold increase.
This revised estimation of BDNF upregulation is consistent with results obtained from in situ hybridization. We observed a 3-to 4-fold increase in the number of BDNF-positive cells, in addition to a 3-to 4-fold increase in the number of silver grains per positive cell. This alone would suggest induction of BDNF mRNA expression by a factor of 10-15 in experimentals versus controls. However, we believe this calculation is also underestimated in two ways: (1) the number of silver grains does not correlate linearly with an increase in mRNA expression, but plateaus at an upper limit; and (2) only neurons that showed twice the number of silver grains as control neurons were counted as positive, thereby excluding many neurons that displayed moderately elevated BDNF expression. Taking these factors into account, we estimate an even greater increase in neurotrophin and neurotrophin receptor upregulation during targeted neuronal degeneration. This strengthens the likelihood that such intercellular signaling plays a significant role in the directed cellular migration, differentiation, and integration previously seen by transplanted immature neurons and neural precursors within regions of neuronal apoptosis.
Upregulation of specific neurotrophins within regions undergoing targeted neuronal degeneration provides some insight into possible intercellular signaling. Selective degeneration of a specific neuronal subpopulation using this approach of targeted apoptosis preserves all other cell populations, enabling analysis of the responses of neighboring cells. There is no inflammatory reaction, no necrotic cell death with release of intracellular contents by lysed cells, nor nonspecific injury to surrounding neuronal, glial, or other cellular populations that frequently accompanies experimental perturbations including excitotoxicity, neurotoxicity, and hypoxic-ischemic injury (2, 13-15, 18, 19, 24, 29, 37, 53, 55) . The full-length trkB receptor is highly expressed by developing neocortical neurons, and, in the current study, increased full-length trkB message is the first response detected following induction of apoptotic cell death within callosal projecting pyramidal neurons. The subsequent upregulation of BDNF, NT-4/5, and NT-3 mRNA in immediately adjacent interneurons may represent the response by interneurons to yet unidentified soluble signals or changes in synaptic activity of the degenerating pyramidal neurons.
The induction of catalytic, full-length trkB receptors within neurons undergoing apoptosis, and the induction of the ligands BDNF, NT-4/5, and NT-3 by neighboring neurons that are synaptic partners in local circuitry, may serve the same purposes as during initial local circuit refinement during corticogenesis (32, 51, 76) . BDNF and NT-4/5 influence the differentiation and survival of both excitatory and inhibitory cortical neurons (9, 10) . During development, the eventual number of pyramidal neurons and interneurons within cortex is thought to be regulated by cell death, implying that local interactions between these two subpopulations, including neurotrophin signaling, may be responsible for final neuronal complements and proportions (11, 35) . The increased expression of BDNF, NT-4/5, and NT-3 by interneurons following targeted apoptosis may represent the reemergence of a developmental program of gene expression to regulate neuronal numbers and match local circuit requirements. Degeneration of pyramidal neurons may induce reexpression of these neurotrophins and potentially a much larger set of other control molecules not yet identified, in order to maintain the established balance between neuronal populations. Transplanted immature neurons and neural precursors appear to take advantage of the resulting instructive and permissive microenvironment to support their survival and differentiation.
Taken together, the current results indicate that targeted apoptosis of neocortical pyramidal projection neurons modifies neurotrophin, receptor, and very likely a broader program of developmental gene expression via mechanisms including intercellular signaling between degenerating pyramidal neurons and surrounding interneurons that are their synaptic partners. These intercellular signals may act to modify the number and proportions of neuronal populations and thereby refine local cellular circuitry. Further understanding of these and other developmental controls over neocortical projection neuron migration, differentiation, and survival, and the mechanisms regulating these intercellular signals, could provide insight regarding molecular regulation of neuronal differentiation during neocortical development and regarding intercellular signaling induced by apoptosis. Manipulation of these developmental controls could provide approaches toward potentially therapeutic complex circuit reconstruction via directed differentiation of transplanted or endogenous immature neurons or neural precursors within neocortex and other regions of the CNS.
